As for the surgical approach, the risk of inadvertent dissemination of occult malignancies of presumed benign tissue must be considered, as COL1A1–PDGFB fusion uterine sarcomas could be judged as benign leiomyoma on imaging (33). The gene discussed is COL1A1; the disease is leiomyoma.